The group fears patients with faulty implants will not receive proper compensation for premature failure, according to the report.
The fear stems from a report associating metal-on-metal implants with high revision surgery rates and an elevated risk of tissue damage due to metal shavings from the implant, the report says.
“The US Drug Watchdog is calling the U.S. metal on metal hip implant fiasco the largest medical device failure in U.S. history involving 500,000 U.S. citizens, and they are convinced there are hundreds of thousands of U.S. citizens who are recipients of a metal-on-metal hip implant that has failed, or will fail prematurely,” reads the group’s website.
More Articles on Supply Chain:
Medical Device Recalls Increased 97% Over Past 10 Years
4 Strategies to Enhance Supply Chain Efficiency
FDA Approves Otezla for Psoriatic Arthritis Treatment
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
